Drug Therapies For Pre-Kidney Transplant Show Promise
A recent research study has shown promise for a novel drug in improving outcomes for kidney transplant patients. The second-generation cancer drug, called carfilzomib, may help reduce the production of antibodies in potential transplant patients.
While antibodies are normally good things, pre-transplant patients need reduced antibodies to prevent rejection of their new organ. Read the full story here. >>
Now We Join in Celebration
As we celebrate 50 years of providing excellence in transplantation, breakthrough treatments and compassionate coordination of care to the region, we invite you to join us in a 50-day countdown to the anniversary of the first surgery that launched Cincinnati’s most comprehensive transplant program.
Celebrate with us by sharing our stories of transplantation with your social media network using #UCHealthTransplant via Facebook, Twitter or Instagram!
For more information about UC Health transplant services, please visit uchealth.com/transplant.